{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:41:38Z","timestamp":1786736498893,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Saudi J Kidney Dis Transpl"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/1319-2442.279948","type":"journal-article","created":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T07:28:48Z","timestamp":1583220528000},"page":"254","source":"Crossref","is-referenced-by-count":15,"title":["Neurocysticercosis"],"prefix":"10.4103","volume":"31","author":[{"given":"Tayyaba","family":"Siddiqua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Habeeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1319-2442.279948-1","first-page":"159821","article-title":"Neurocysticercosis: A review","author":"del","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"key-10.4103\/1319-2442.279948-2","doi-asserted-by":"crossref","unstructured":"Guyatt GH, Oxman AD, Vist GE, et al. GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"key-10.4103\/1319-2442.279948-3","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.actatropica.2016.11.015","article-title":"Neurocysticercosis infection and disease-a review","author":"Gripper","year":"2017","journal-title":"Acta Trop"},{"key":"key-10.4103\/1319-2442.279948-4","doi-asserted-by":"crossref","unstructured":"Del Brutto OH, Garcia HH. Taenia solium: Biological characteristics and life cycle. In: Cysticercus is of Human Nervous System. 1st ed. Berlin: Springer-Verlag Berlin and Herdelberg GmbH and Co. KG; 2014. p. 1121.","DOI":"10.1007\/978-3-642-39022-7_2"},{"key":"key-10.4103\/1319-2442.279948-5","unstructured":"Bogitsh B, Carter C, Oeltmann T. Human Parasitology. 4th ed. Amsterdam: Academic Press; 2013. p. 241-4."},{"key":"key-10.4103\/1319-2442.279948-6","first-page":"27","article-title":"Awareness of neurocysticercosis: A study from northwest India","author":"Girotra","year":"2011","journal-title":"Ann Indian Acad Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0972-2327","issn-type":"print"},{"key":"key-10.4103\/1319-2442.279948-7","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1093\/cid\/cix1084","article-title":", Coyle CM, Rajshekhar V, et al.Diagnosis and treatment of neurocysticercosis: 2017 clinical practice guidelines by the infectious diseases society of America (IDSA) and the American society of tropical medicine and hygiene (ASTMH)","author":"White","year":"2018","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/1319-2442.279948-8","unstructured":"King CH. Cestodes (Tapeworm). In: Mandell GI, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett\u2019s Principles and Practice of Infectious Diseases. 5th ed., Vol. 2. United Kingdom: Churchill Livingstone; 2000. p. 2956-64."},{"key":"key-10.4103\/1319-2442.279948-9","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1473-3099(02)00454-1","article-title":"Neurocysticercosis: An update","author":"Carpio","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"key-10.4103\/1319-2442.279948-10","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1212\/CPJ.0b013e31828d9f17","article-title":"Neurocysti- cercosis: Five new things","author":"Carpio","year":"2013","journal-title":"Neurol Clin Pract"},{"key":"key-10.4103\/1319-2442.279948-11","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/infdis\/164.5.1007","article-title":"Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis","author":"Wilson","year":"1991","journal-title":"J Infect Dis"},{"key":"key-10.4103\/1319-2442.279948-12","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1474-4422(05)70194-0","article-title":"Neurocysticercosis: Updated concepts about an old disease","author":"Garcia","year":"2005","journal-title":"Lancet Neurol"},{"key":"key-10.4103\/1319-2442.279948-13","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/CMR.15.4.747-756.2002","article-title":"Current consensus guidelines for treatment of neuro- cysticercosis","author":"Garc\u00eda","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"key-10.4103\/1319-2442.279948-14","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1086\/656395","article-title":"Tolllike receptor 4 polymorphism and its association with symptomatic neurocysticercosis","author":"Verma","year":"2010","journal-title":"J Infect Dis"},{"key":"key-10.4103\/1319-2442.279948-15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jneuroim.2014.07.018","article-title":"Association of ICAM-1 K469E polymorphism with neurocysticercosis","author":"Singh","year":"2014","journal-title":"J Neuroimmunol"},{"key":"key-10.4103\/1319-2442.279948-16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1528-1157.1999.tb02080.x","article-title":"Family studies and human leukocyte antigen class II typing in Indian probands with seizures in association with single small enhancing computed tomography lesions","author":"Jain","year":"1999","journal-title":"Epilepsia"},{"key":"key-10.4103\/1319-2442.279948-17","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/epi.12978","article-title":"Multifactorial basis of epilepsy in patients with neurocysticercosis","author":"Carpio","year":"2015","journal-title":"Epilepsia"},{"key":"key-10.4103\/1319-2442.279948-18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijpddr.2014.07.002","article-title":"Repurposing drugs for the treatment and control of helminth infections","author":"Panic","year":"2014","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"key-10.4103\/1319-2442.279948-19","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1007\/s11095-015-1677-3","article-title":"Dual drug delivery using lactic acid conjugated SLN for effective management of neurocysticercosis","author":"Devi","year":"2015","journal-title":"Pharm Res"},{"key":"key-10.4103\/1319-2442.279948-20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/1091581815569582","article-title":"Preclinical studies on the pharmacokinetics, safety, and toxicology of oxfendazole: Toward first in human studies","author":"Codd","year":"2015","journal-title":"Int J Toxicol"}],"container-title":["Saudi Journal of Kidney Diseases and Transplantation"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:42:42Z","timestamp":1786732962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1319-2442.279948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"alternative-id":["279948"],"URL":"https:\/\/doi.org\/10.4103\/1319-2442.279948","relation":{},"ISSN":["1319-2442"],"issn-type":[{"value":"1319-2442","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}